AI reads biopsy slides to predict chemo success in breast cancer

NCT ID NCT07327970

First seen Jan 09, 2026 · Last updated May 13, 2026 · Updated 23 times

Summary

This study is testing a new artificial intelligence (AI) tool called Ataraxis that analyzes images of breast cancer biopsy slides to predict how well a patient will respond to chemotherapy before surgery. The goal is to see if the AI can be easily used in real-world clinics and if its predictions match actual outcomes. About 150 adults with early-stage breast cancer will take part, and their doctors will not see the AI results until after surgery to ensure the study is fair. No extra procedures are needed beyond standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea

    RECRUITING

    Incheon, 21431, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.